Compare BLRX & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLRX | HKIT |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | Israel | China |
| Employees | 28 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 121.6M |
| IPO Year | 2011 | 2023 |
| Metric | BLRX | HKIT |
|---|---|---|
| Price | $2.93 | $2.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 23.2K | ★ 603.8K |
| Earning Date | 11-24-2025 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,735,000.00 | $1,812,901.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.15 |
| 52 Week High | $14.70 | $4.18 |
| Indicator | BLRX | HKIT |
|---|---|---|
| Relative Strength Index (RSI) | 39.72 | 58.40 |
| Support Level | $2.85 | $1.92 |
| Resistance Level | $3.03 | $2.22 |
| Average True Range (ATR) | 0.17 | 0.19 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 18.39 | 66.21 |
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.